IXICO (LON:IXI) Trading Up 13.5% – Should You Buy?

IXICO plc (LON:IXI) shares traded up 13.5% during trading on Tuesday . The stock traded as high as GBX 9.50 and last traded at GBX 9.22. 428,679 shares changed hands during mid-day trading, an increase of 245% from the average daily volume of 124,079 shares. The stock had previously closed at GBX 8.12.

IXICO Price Performance

The company has a 50-day simple moving average of GBX 7.98 and a 200-day simple moving average of GBX 8.83. The stock has a market cap of £20.11 million, a PE ratio of -4.73, a PEG ratio of -0.38 and a beta of 0.13. The company has a debt-to-equity ratio of 5.22, a current ratio of 2.83 and a quick ratio of 4.90.

IXICO (LON:IXI) last posted its quarterly earnings results on Tuesday, May 19th. The company reported GBX (1.21) earnings per share for the quarter. The company had revenue of GBX 395 million for the quarter. IXICO had a negative return on equity of 16.18% and a negative net margin of 24.98%. Sell-side analysts anticipate that IXICO plc will post -289.3584879 EPS for the current fiscal year.

About IXICO

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.